Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 4
1979 9
1980 15
1981 16
1982 47
1983 79
1984 109
1985 150
1986 177
1987 171
1988 239
1989 340
1990 348
1991 460
1992 575
1993 629
1994 747
1995 831
1996 876
1997 1028
1998 1076
1999 1151
2000 1359
2001 1403
2002 1420
2003 1577
2004 1590
2005 1743
2006 1783
2007 1824
2008 2010
2009 2086
2010 2280
2011 2462
2012 2555
2013 2707
2014 2785
2015 2701
2016 2433
2017 2348
2018 2107
2019 961
2020 20
Text availability
Article attribute
Article type
Publication date

Search Results

44,408 results
Results by year
Filters applied: . Clear all
Page 1
Closed Or Open after Source Control Laparotomy for Severe Complicated Intra-Abdominal Sepsis (the COOL trial): study protocol for a randomized controlled trial
Kirkpatrick AW, et al. World J Emerg Surg 2018 - Clinical Trial. PMID 29977328 Free PMC article.
Bio-mediator outcomes for participating centers will involve measurement of interleukin (IL)-6 and IL-10, procalcitonin, activated protein C (APC), high-mobility group box protein-1, complement factors, and mitochondrial DNA. ...
Bio-mediator outcomes for participating centers will involve measurement of interleukin (IL)-6 and IL-10, procalcitonin, activated pr …
Innate immune alterations are elicited in microglial cells before plaque deposition in the Alzheimer's disease mouse model 5xFAD
Boza-Serrano A, et al. Sci Rep 2018. PMID 29367720 Free PMC article.
Using mass spectrometry analysis of microglial cells with bioinformation analysis, we found JAK/STAT, p38 MAPK and Interleukin pathways affected in microglial cells before plaque deposition at 6 weeks. ...
Using mass spectrometry analysis of microglial cells with bioinformation analysis, we found JAK/STAT, p38 MAPK and Interleukin pathwa …
Could the biomarker levels in saliva help distinguish between healthy implants and implants with peri-implant disease? A systematic review
Gomes AM, et al. Arch Oral Biol 2018. PMID 30300769
RESULTS: Lower salivary levels of interleukin 1β were found in healthy implants than in inflamed implants. A significantly positive correlation was found between the salivary levels of IL-6 and peri-implant inflammatory conditions. ...
RESULTS: Lower salivary levels of interleukin 1β were found in healthy implants than in inflamed implants. A significantly positive c …
Clinical and radiographic periodontal status and whole salivary cotinine, IL-1β and IL-6 levels in cigarette- and waterpipe-smokers and E-cig users
Mokeem SA, et al. Environ Toxicol Pharmacol 2018. PMID 29843053
The aim was to compare the clinical (plaque index [PI], bleeding on probing [BOP], probing pocket depth [PPD] and clinical attachment loss [CAL]) and radiographic (marginal bone loss [MBL]) periodontal parameters and whole salivary cotinine, interleukin (IL)-1β and IL-6 levels among cigarette-smokers, waterpipe-smokers, E-cig users and never-smokers. ...
The aim was to compare the clinical (plaque index [PI], bleeding on probing [BOP], probing pocket depth [PPD] and clinical attachment loss [ …
Increased serum IL-17 and decreased serum IL-10 and IL-35 levels correlate with the progression of COPD
Jiang S, et al. Int J Chron Obstruct Pulmon Dis 2018. PMID 30154651 Free PMC article.
PURPOSE: This study aimed to measure the serum levels of interleukin (IL)-17, IL-10, and IL-35 in patients with stable chronic obstructive pulmonary disease (COPD) and disclose the correlations between their expression levels and clinical factors of patients. ...
PURPOSE: This study aimed to measure the serum levels of interleukin (IL)-17, IL-10, and IL-35 in patients with stable chronic obstru …
Interleukin-1β, interleukin-1 receptor antagonist, interleukin-6, interleukin-10, and tumor necrosis factor-α levels in CSF and serum in relation to the clinical diversity of Parkinson's disease.
Karpenko MN, et al. Cell Immunol 2018. PMID 29478949
Several parameters representing the clinical diversity of Parkinson's disease (PD), including severity, phenotypes, cognitive decline, anxiety and depression were analyzed to examine the link with interleukin-1β (IL-1β), the interleukin-1 receptor antagonist (IL-1RA), IL-6, IL-10, and tumor necrosis factor-α (TNFα) and also to determine the relationship between levels of these factors in serum and cerebrospinal fluid (CSF). ...
Several parameters representing the clinical diversity of Parkinson's disease (PD), including severity, phenotypes, cognitive decline, anxie …
Increased plasma IL-17, IL-31, and IL-33 levels in chronic spontaneous urticaria
Lin W, et al. Sci Rep 2017. PMID 29259273 Free PMC article.
Interleukin(IL)-17, IL-31, and IL-33 are involved in some immune response. The aim of this study was to quantify plasma IL-17, IL-31, and IL-33 levels in CSU patients and to examine their relationships with disease severity. ...
Interleukin(IL)-17, IL-31, and IL-33 are involved in some immune response. The aim of this study was to quantify plasma IL-17, IL-31,
44,408 results
Jump to page
Feedback